Tag Archives: Radiopharmaceutical Preclinical CRO Market Growth

The contract research organization (CRO) market for radiopharmaceuticals is a vital component in the progression of preclinical research within the domain of radiopharmaceuticals and is characterized by its dynamic nature. The market for radiopharmaceutical preclinical CROs is anticipated to expand at a CAGR of 8.5% during the forecast period of 2024 to 2032. This growth will be propelled by developments ...